Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management

@article{Spiller2013OverdoseOD,
  title={Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management},
  author={Henry A. Spiller and Hannah L. Hays and Alfred Aleguas},
  journal={CNS Drugs},
  year={2013},
  volume={27},
  pages={531-543}
}
The prevalence of attention-deficit hyperactivity disorder (ADHD) in the USA is estimated at approximately 4–9 % in children and 4 % in adults. It is estimated that prescriptions for ADHD medications are written for more than 2.7 million children per year. In 2010, US poison centers reported 17,000 human exposures to ADHD medications, with 80 % occurring in children <19 years old and 20 % in adults. The drugs used for the treatment of ADHD are diverse but can be roughly separated into two… 
Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder
TLDR
The safety and efficacy of ATX in adults with ADHD are reviewed, including data in special populations, functional outcomes, as well as provider and patient real-world perceptions.
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
TLDR
There is substantial body of evidence to suggest that MPH is an effective and safe treatment option for adults with ADHD.
Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature
TLDR
There was only a minimal increase in side-effects when ADHD medication (therapeutic doses) was taken with alcohol and none of the reviewed studies showed severe sequelae among those who had overdosed on ADHD medication and other coingestants, including alcohol.
Development of a peptide targeting dopamine transporter to improve ADHD-like deficits
TLDR
An interaction between DAT and dopamine D2 receptor (D2R) as a novel target to develop potential therapeutics for the treatment of ADHD is investigated by using an interfering peptide (TAT-DATNT) to dissociate this protein complex.
Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis
TLDR
Network meta-analysis offered a broader overview on the available treatments for ADHD, especially for safety issues, and contributes towards evidence gathering and clinical practice decisions.
Benzodiazepine Abuse in the Attention Deficit Hyperactivity Disorder: A Case Report.
TLDR
This case report supports using the long-acting injectable formulation of aripiprazole as a potential treatment for delusional disorder after seeing a relatively quick response to the medication, before reaching steady state, without the recommended oral overlap, and at a lower dose than is typically recommended for treatment of schizophrenia.
Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors
TLDR
Investigating how ADHD drugs could modulate, through interaction with catecholamine receptors, basal and glutamate-induced excitability of pyramidal neurons in the prefrontal cortex (PFC), a region which plays a major role in control of attention and impulsivity shows that increase inexcitability of PFC neurons in basal conditions and via NMDA receptor activation may be involved in the therapeutic response to ADHD drugs.
Toxicity of acute exploratory amphetamine-salt medication in amphetamine-naïve pediatrics: a retrospective cohort study
TLDR
The median dose of amphetamines ingested by patients receiving benzodiazepines was greater than those not receiving benzidiazepines, and Prospective studies should be performed to assess triage guidelines and referral doses.
Suicide Attempt with High Dose Long Acting Methylphenidate Ingestion: A Case Presentation
TLDR
It is suggested that higher doses of MPH-OROS could be tolerated well under fine clinical observation and management; although more larger scale studies in humans are needed.
Amphetamines: Potent Recreational Drug of Abuse
TLDR
The functions of the amphetamines as recreation drug of abuse are explored, considered by compulsive drug-seeking and drug use and a phenomenon notorious as amphetamine psychosis.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 146 REFERENCES
Pharmacokinetics and Clinical Effectiveness of Methylphenidate
TLDR
It is difficult to predict which children will have a favourable response to methylphenidate, and therefore dosage must be titrated for optimal effect and avoidance of toxicity in each child, and further studies of the relationship between the pharmacokinetic and pharmacodynamic properties are required to allow the development of optimal dosage regimens.
Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder
  • T. Wilens
  • Biology, Psychology
    Journal of clinical psychopharmacology
  • 2008
TLDR
Overall, the changes in catecholaminergic tone clinically manifest as improvements in attention deficit, distractibility, and motor hyperactivity in patients with ADHD.
Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.
TLDR
Among children and adolescents aged 8 to 18, atomoxetine was superior to placebo in reducing ADHD symptoms and in improving social and family functioning symptoms.
Pharmacokinetic and Pharmacodynamic Drug Interactions in the Treatment of Attention-Deficit Hyperactivity Disorder
TLDR
Psychostimulant pharmacology is examined, reported drug-drug interactions are summarized, underlying pharmacokinetic and pharmacodynamic considerations for interactions are explored and it appears that these agents may be safely coadministered.
Lisdexamfetamine Dimesylate: A Prodrug Stimulant for the Treatment of ADHD in Children and Adults
TLDR
This review of LDX presents the efficacy, safety, and pharmacokinetic profile of this novel stimulant medication, and is intended to help clinicians understand its role in treating children and adults with ADHD.
Dyskinesias associated with atomoxetine in combination with other psychoactive drugs
TLDR
Clinicians should be aware of emergent dyskinesias when combining atomoxetine with dopaminergic, noradrenergic, or serotonergic medications.
Benign Clinical Course Following Atomoxetine Overdose
TLDR
An accidental overdose with almost four times the maximum recommended daily dose of atomoxetine resulted in a benign clinical course without intervention in a 12-yr-old male.
Advances in understanding and treating ADHD
TLDR
Cognitive behavioral interventions have proven popular in the treatment of adult ADHD, especially within the adult population who cannot or will not use medications, along with the many medication-treated patients who continue to show residual disability.
alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.
TLDR
How compounds like guanfacine and the traditional stimulant medications can reduce the core symptoms of ADHD by optimizing the neurochemical environment in the prefrontal cortex (PFC) is explained.
Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults.
  • F. Taylor, J. Russo
  • Psychology, Medicine
    Journal of child and adolescent psychopharmacology
  • 2000
TLDR
Modafinil may be a viable alternative to conventional stimulants for the treatment of adults with ADHD and scores on the DSM-IV ADHD Checklist were significantly improved over the placebo condition following treatment with both active medications.
...
1
2
3
4
5
...